BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29909754)

  • 1. Angioimmunoblastic T-cell lymphoma: a prognostic model from a retrospective study.
    Hong H; Fang X; Wang Z; Huang H; Lam ST; Li F; Peng C; Tian Y; Lin S; Lin T
    Leuk Lymphoma; 2018 Dec; 59(12):2911-2916. PubMed ID: 29909754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma.
    Yamasaki S; Yoshida S; Kato K; Choi I; Imamura Y; Kohno K; Henzan H; Tanimoto K; Ogawa R; Suehiro Y; Miyamoto T; Eto T; Ohshima K; Akashi K; Iwasaki H;
    Int J Hematol; 2020 Jul; 112(1):74-83. PubMed ID: 32297159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study.
    Park SI; Horwitz SM; Foss FM; Pinter-Brown LC; Carson KR; Rosen ST; Pro B; Hsi ED; Federico M; Gisselbrecht C; Schwartz M; Bellm LA; Acosta M; Advani RH; Feldman T; Lechowicz MJ; Smith SM; Lansigan F; Tulpule A; Craig MD; Greer JP; Kahl BS; Leach JW; Morganstein N; Casulo C; Shustov AR;
    Cancer; 2019 May; 125(9):1507-1517. PubMed ID: 30694529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphoma.
    Yamasaki S; Chihara D; Kim SW; Kawata T; Mizuta S; Ago H; Chou T; Yamane T; Uchiyama H; Oyake T; Miura K; Saito B; Taji H; Nakamae H; Miyamoto T; Fukuda T; Kanda J; Atsuta Y; Suzuki R
    Int J Hematol; 2019 Feb; 109(2):175-186. PubMed ID: 30430419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
    Chihara D; Fanale MA; Miranda RN; Noorani M; Westin JR; Nastoupil LJ; Hagemeister FB; Fayad LE; Romaguera JE; Samaniego F; Turturro F; Lee HJ; Neelapu SS; Rodriguez MA; Wang M; Fowler NH; Davis RE; Medeiros LJ; Hosing C; Nieto YL; Oki Y
    Br J Haematol; 2017 Mar; 176(5):750-758. PubMed ID: 27983760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.
    Federico M; Rudiger T; Bellei M; Nathwani BN; Luminari S; Coiffier B; Harris NL; Jaffe ES; Pileri SA; Savage KJ; Weisenburger DD; Armitage JO; Mounier N; Vose JM
    J Clin Oncol; 2013 Jan; 31(2):240-6. PubMed ID: 22869878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma.
    Kato A; Imai Y; Aoki K; Tabata S; Matsushita A; Hashimoto H; Takahashi T; Ishikawa T
    Ann Hematol; 2014 Jul; 93(7):1185-91. PubMed ID: 24526138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of angioimmunoblastic T-cell lymphoma in China and C-reactive protein as an independent prognostic factor.
    Li Y; Yang C; Mao L; Wang J; Li C; Qian W
    Medicine (Baltimore); 2017 Sep; 96(39):e8091. PubMed ID: 28953629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project.
    Advani RH; Skrypets T; Civallero M; Spinner MA; Manni M; Kim WS; Shustov AR; Horwitz SM; Hitz F; Cabrera ME; Dlouhy I; Vassallo J; Pileri SA; Inghirami G; Montoto S; Vitolo U; Radford J; Vose JM; Federico M
    Blood; 2021 Jul; 138(3):213-220. PubMed ID: 34292324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angioimmunoblastic T-cell lymphoma: treatment strategies and prognostic factors from a retrospective multicenter study in China.
    Zhang C; Mi L; Wu M; Liu W; Ma H; Ren J; Zhao L; Wang X; Song Y; Zhu J
    Leuk Lymphoma; 2022 May; 63(5):1152-1159. PubMed ID: 34957894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan.
    Tokunaga T; Shimada K; Yamamoto K; Chihara D; Ichihashi T; Oshima R; Tanimoto M; Iwasaki T; Isoda A; Sakai A; Kobayashi H; Kitamura K; Matsue K; Taniwaki M; Tamashima S; Saburi Y; Masunari T; Naoe T; Nakamura S; Kinoshita T
    Blood; 2012 Mar; 119(12):2837-43. PubMed ID: 22308294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features, outcome and prognostic factors of 87 patients with angioimmunoblastic T cell lymphoma in Taiwan.
    Kao HW; Lin TL; Shih LY; Dunn P; Kuo MC; Hung YS; Wu JH; Tang TC; Chang H; Kuo TT; Ou CW; Wang PN
    Int J Hematol; 2016 Aug; 104(2):256-65. PubMed ID: 27095042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma.
    Lee YP; Yoon SE; Cho J; Ko YH; Jo H; Kim SJ; Kim WS
    Ann Hematol; 2022 Jul; 101(7):1535-1543. PubMed ID: 35639152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification.
    Arrowsmith ER; Macon WR; Kinney MC; Stein RS; Goodman SA; Morgan DS; Flexner JM; Cousar JB; Jagasia MH; McCurley TL; Greer JP
    Leuk Lymphoma; 2003 Feb; 44(2):241-9. PubMed ID: 12688340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B2 microglobulin is a novel prognostic marker of Angioimmunoblastic T-cell lymphoma.
    Shang Y; Fu X; Chang Y; Li Y; Zhang M
    Sci Rep; 2018 Aug; 8(1):12907. PubMed ID: 30150635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical analysis of 12 patients with angioimmunoblastic T cell lymphoma].
    Wang SH; Wang QS; Sun L; Li HH; Zhao Y; Jia BJ; Zhang XL; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1208-10. PubMed ID: 21129262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and prognostic factors of angioimmunoblastic T-cell lymphoma in Taiwan: a single-institution experience.
    Lin HN; Liu CY; Hong YC; Pai JT; Yang CF; Yu YB; Hsiao LT; Chiou TJ; Liu JH; Gau JP; Tzeng CH; Chen PM
    Leuk Lymphoma; 2010 Dec; 51(12):2208-14. PubMed ID: 21054150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological Study of 30 Cases of Peripheral T-cell Lymphoma with Hodgkin and Reed-Sternberg-like B-cells from Japan.
    Eladl AE; Satou A; Elsayed AA; Suzuki Y; Kato S; Asano N; Nakamura S
    Am J Surg Pathol; 2017 Apr; 41(4):506-516. PubMed ID: 28125450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated absolute monocyte count predicts unfavorable outcomes in patients with angioimmunoblastic T-cell lymphoma.
    Yang YQ; Liang JH; Wu JZ; Wang L; Qu XY; Cao L; Zhao XL; Huang DP; Fan L; Li JY; Xu W
    Leuk Res; 2016 Mar; 42():88-92. PubMed ID: 26764222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy.
    Chihara D; Oki Y; Ine S; Yamamoto K; Kato H; Taji H; Kagami Y; Yatabe Y; Nakamura S; Morishima Y
    Leuk Lymphoma; 2009 Dec; 50(12):1999-2004. PubMed ID: 19860627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.